Hiva Azizi
Ottawa, ON K1A0R6, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Sindbis virus self-amplifying replicon is compatible with modified nucleotides mediating expression and vaccine responses in vivo.
Journal: Molecular therapy. Advances
Published: July 25, 2025
Self-amplifying RNAs generated with the modified nucleotides 5-methylcytidine and 5-methyluridine mediate strong expression and immunogenicity in vivo.
Journal: NAR molecular medicine
Published: March 25, 2024
Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.
Journal: Vaccines
Published: January 31, 2024
UV-Inactivated rVSV-M2e-Based Influenza Vaccine Protected against the H1N1 Influenza Challenge.
Journal: Frontiers in bioscience (Landmark edition)
Published: January 28, 2024
Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen.
Journal: Emerging microbes & infections
Published: August 31, 2023
Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines.
Journal: Frontiers in microbiology
Published: May 05, 2022
Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New Dendritic Cell-Targeting Vaccine Approach against HIV-1.
Journal: Journal of virology
Published: May 20, 2021
Transient Liver Damage and Hemolysis Are Associated With an Inhibition of Ebola Virus Glycoprotein-Specific Antibody Response and Lymphopenia.
Journal: The Journal of infectious diseases
Published: May 10, 2021
Last Updated: 09/26/2026